Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY
(646) 856-9261
info@rgenix.com
rgenix-new-york-how-to-make-it-here

Xconomy: New York Biotech – How to make it here

6:15-6:45 PM | The Rgenix Story:

From our beginnings as a small spin-out from Rockefeller University to a world-class team with multiple clinical programs and $40M in Series C funding, our executives tell the story of our Manhattan-based biotechnology company.

Xconomy: New York Biotech – How to make it here | December 18, 2018

Learn More